McAdam LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

McAdam LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 25.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 759 shares of the healthcare conglomerate’s stock after buying an additional 154 shares during the quarter. McAdam LLC’s holdings in UnitedHealth Group were worth $444,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the company. RAM Investment Partners LLC increased its position in UnitedHealth Group by 5.6% in the third quarter. RAM Investment Partners LLC now owns 450 shares of the healthcare conglomerate’s stock worth $263,000 after buying an additional 24 shares during the last quarter. Fulcrum Capital LLC increased its position in UnitedHealth Group by 0.3% in the third quarter. Fulcrum Capital LLC now owns 19,359 shares of the healthcare conglomerate’s stock worth $11,319,000 after buying an additional 63 shares during the last quarter. Wallington Asset Management LLC increased its position in UnitedHealth Group by 4.6% in the third quarter. Wallington Asset Management LLC now owns 36,033 shares of the healthcare conglomerate’s stock worth $21,068,000 after buying an additional 1,583 shares during the last quarter. Courier Capital LLC boosted its holdings in shares of UnitedHealth Group by 233.1% in the third quarter. Courier Capital LLC now owns 4,161 shares of the healthcare conglomerate’s stock worth $2,433,000 after acquiring an additional 2,912 shares during the period. Finally, Detalus Advisors LLC boosted its holdings in shares of UnitedHealth Group by 1.7% in the third quarter. Detalus Advisors LLC now owns 1,673 shares of the healthcare conglomerate’s stock worth $978,000 after acquiring an additional 28 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Finally, Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

Shares of UNH opened at $560.82 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average price is $584.16 and its 200-day moving average price is $536.49. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The stock has a market cap of $517.87 billion, a P/E ratio of 36.54, a P/E/G ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.